drugset / Trial / NCT01982201

Antacid Interaction Study

NCT01982201

Phase 1 Completed 24 enrolled Ardea Biosciences, Inc.
RandomizedParallel-groupOpen-labelBasic science

Summary

This study will assess the potential effects of calcium carbonate and aluminum/magnesium hydroxide-containing antacids on the pharmacokinetics (PK) and pharmacodynamics (PD) of lesinurad in healthy, adult male subjects.

Timeline

Start
2013-11
Primary completion
2013-12
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject CALCIUM CARBONATE Small molecule 500 mg
Subject CALCIUM CARBONATE Small molecule 750 mg
Subject Lesinurad Small molecule 400 mg
Subject MINTOX Unknown 10 ml

Indications

No indication recorded.